RLIP76 regulates PI3K/Akt signaling and chemo-radiotherapy resistance in pancreatic cancer.
Pancreatic cancer is an aggressive malignancy with characteristic metastatic course of disease and resistance to conventional chemo-radiotherapy. RLIP76 is a multi-functional cell membrane protein that functions as a major mercapturic acid pathway transporter as well as key regulator of receptor-lig...
Main Authors: | Kathryn Leake, Jyotsana Singhal, Lokesh Dalasanur Nagaprashantha, Sanjay Awasthi, Sharad S Singhal |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3317991?pdf=render |
Similar Items
-
RLIP76, a glutathione-conjugate transporter, plays a major role in the pathogenesis of metabolic syndrome.
by: Jyotsana Singhal, et al.
Published: (2011-01-01) -
RLIP76, a non-ABC transporter, and drug resistance in epilepsy
by: Awasthi Yogesh C, et al.
Published: (2005-09-01) -
Rlip Depletion Suppresses Growth of Breast Cancer
by: Chhanda Bose, et al.
Published: (2020-06-01) -
RLIP76: A Structural and Functional Triumvirate
by: Jasmine Cornish, et al.
Published: (2021-05-01) -
Rlip76: An Unexplored Player in Neurodegeneration and Alzheimer’s Disease?
by: Ashly Hindle, et al.
Published: (2022-05-01)